Flublok Trivalent Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Flublok Trivalent Influenza Vaccine is a clear and colourless solution.
One dose (0.5 mL) contains: Influenza virus haemagglutinin (HA) proteins, of the following strains*: A/Wisconsin/67/2022 (H1N1)pdm09 - like strain (A/West Virginia/30/2022) 45 micrograms HA; A/District of Columbia/27/2023 (H3N2) - like virus (A/District of Columbia/27/2023 (H3N2) 45 micrograms HA; B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021) 45 micrograms HA.
*produced by recombinant DNA technology using a baculovirus expression system in a continuous insect cell line that is derived from Sf9 cells of the fall armyworm, Spodoptera frugiperda.
This vaccine complies with the World Health Organization (WHO) recommendation (Northern Hemisphere) and EU recommendation for the 2025/2026 season.
Flublok Trivalent may contain traces of octylphenol ethoxylate.
Excipients/Inactive Ingredients: Polysorbate 20 (Tween 20), Sodium chloride, Sodium phosphate monobasic, Sodium phosphate dibasic, Water for injection.

Flublok Trivalent Description

influenza vaccine

Manufacturer:

Sanofi

Distributor:

Zuellig